A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

Also called NCT05971693

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 188 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05971693
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, Canada, Croatia, Czechia, Germany, Italy, Lithuania, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05971693. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-12 (actual); primary completion 2024-12-10 (actual). Results posted on 2026-03-25.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator
Acronym
Omny-IRE
Intervention (Device)
OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05971693
Content hash
e6280cafb3936fe8dbf9aa01eb45375a576661f47d602550dd16a0a6f5063e6b